Catalyst
Slingshot members are tracking this event:
The results of the REVEAL study of Anacetrapib (MK-0859) in LDL-C lowering will be presented at the European Society of Cardiology meeting on Aug. 29, 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MRK | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 29, 2017
Occurred Source:
http://www.mrknewsroom.com/news-release/research-and-development-news/merck-announces-results-reveal-outcomes-study-anacetrapib
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ldl-c, Anacetrapib, Mk-0859
